All sterile drug preparations remaining within expiry prepared from Hydromorphone Base Solution dispensed between October 16, 2017 and November 17, 2017, Compounded by Intrathecal Compounding Specialists, Scott, LA 70583.
Published February 14, 2018 · Recall initiated: November 30, 2017
Summary
FDA records drug Class II recall D-0321-2018, published February 14, 2018 and initiated November 30, 2017. Recalling firm: Intrathecal Compounding Specialist, LLC; Status: Terminated; Reported quantity: Unknown; Lot: All lots remaining within expiry (BUDs between November 15, 2017 and December 16, 2017). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of sterility assurance.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Intrathecal Compounding Specialist, LLC
- Distributor
- Nationwide
- Lot
- All lots remaining within expiry (BUDs between November 15, 2017 and December 16, 2017).
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAll sterile drug preparations remaining within expiry prepared from Morphine Sulfate PF Base SolutionFebruary 14, 2018
- FDACiclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDCFebruary 14, 2018
- FDARelumins Advanced Glutathione kits, 900 mg vials, 1500 mg vials and 3000 mg vialsFebruary 14, 2018
- FDARelumins Vitamin C Solvent ampulesFebruary 14, 2018
- FDASyngo.plaza Picture Archiving and Communication System (PACS) with software version VB20A; Model numbers:February 7, 2018
- FDAAffixus Hip Fracture Nail, RH 130 DEG 9MM X 340MMFebruary 7, 2018
Questions about this recall
Was All sterile drug preparations remaining within expiry prepared from Hydromorphone Base Solution dispensed between October 16, 2017 and November 17, 2017, Compounded by Intrathecal Compounding Specialists, Scott, LA 70583. recalled?
Yes. FDA published recall D-0321-2018 on February 14, 2018. Reported hazard: Lack of sterility assurance.
What should I do if I have this product?
Voluntary: Firm initiated · Letter